Safer dialysis for the most vulnerable? new blood thinner trial aims to reduce bleeding risk
Disease control
Recruiting now
This study is testing a new, short-acting blood thinner called Niyad for patients with sudden kidney failure who need continuous dialysis but cannot use standard blood thinners due to a high risk of bleeding. The goal is to see if Niyad can safely prevent the dialysis filter from…
Phase: NA • Sponsor: Talphera, Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC